SI9400005A - Novel opioid peptide analogs - Google Patents
Novel opioid peptide analogs Download PDFInfo
- Publication number
- SI9400005A SI9400005A SI9400005A SI9400005A SI9400005A SI 9400005 A SI9400005 A SI 9400005A SI 9400005 A SI9400005 A SI 9400005A SI 9400005 A SI9400005 A SI 9400005A SI 9400005 A SI9400005 A SI 9400005A
- Authority
- SI
- Slovenia
- Prior art keywords
- phe
- tic
- tyr
- boc
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9300012A SE9300012D0 (sv) | 1993-01-05 | 1993-01-05 | New peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
SI9400005A true SI9400005A (en) | 1994-12-31 |
Family
ID=20388466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9400005A SI9400005A (en) | 1993-01-05 | 1994-01-05 | Novel opioid peptide analogs |
Country Status (25)
Country | Link |
---|---|
US (1) | US5602099A (fi) |
EP (1) | EP0678099A1 (fi) |
JP (1) | JPH08505386A (fi) |
KR (1) | KR960700269A (fi) |
CN (1) | CN1096515A (fi) |
AP (1) | AP508A (fi) |
AU (1) | AU681372B2 (fi) |
CA (1) | CA2152380A1 (fi) |
CZ (1) | CZ171195A3 (fi) |
EE (1) | EE9400326A (fi) |
FI (1) | FI953302A0 (fi) |
HU (1) | HUT72597A (fi) |
IL (1) | IL108169A0 (fi) |
IS (1) | IS4115A (fi) |
LV (1) | LV10962B (fi) |
MX (1) | MX9400255A (fi) |
NO (1) | NO952650L (fi) |
NZ (1) | NZ259597A (fi) |
PL (1) | PL309778A1 (fi) |
SE (1) | SE9300012D0 (fi) |
SI (1) | SI9400005A (fi) |
SK (1) | SK83995A3 (fi) |
WO (1) | WO1994015959A1 (fi) |
YU (1) | YU394A (fi) |
ZA (1) | ZA9455B (fi) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112111A (en) * | 1993-12-23 | 2000-07-16 | Novo Nordisk As | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them |
IS4261A (is) * | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
IL114046A0 (en) * | 1994-06-20 | 1995-10-31 | Astra Ab | New opioid peptide antagonists |
RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
US6184208B1 (en) | 1994-06-29 | 2001-02-06 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
SE9402880D0 (sv) * | 1994-08-30 | 1994-08-30 | Astra Ab | New peptide derivatives |
US5780589A (en) * | 1994-11-30 | 1998-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
CA2216532A1 (en) * | 1995-03-29 | 1996-10-31 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
EP0837857A4 (en) * | 1995-03-29 | 1998-08-05 | Merck & Co Inc | FARNESYL-PROTEIN TRANSFERASE INHIBITORS |
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
SE9600769D0 (sv) * | 1996-02-28 | 1996-02-28 | Astra Ab | Compounds useful as analgesic |
CA2291778A1 (en) * | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
US6703381B1 (en) * | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
US6306576B1 (en) * | 1999-02-19 | 2001-10-23 | Cleveland Clinic Foundation | Diagnostic methods for asthma |
US7601739B2 (en) | 2003-08-08 | 2009-10-13 | Virgina Commonwealth University | Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases |
WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
US20060069086A1 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
WO2015200828A1 (en) * | 2014-06-27 | 2015-12-30 | H. Lee Moffit Cancer Center And Research Institute, Inc. | Conjugates for immunotherapy |
-
1993
- 1993-01-05 SE SE9300012A patent/SE9300012D0/xx unknown
- 1993-12-20 KR KR1019950702750A patent/KR960700269A/ko not_active Application Discontinuation
- 1993-12-20 HU HU9502041A patent/HUT72597A/hu unknown
- 1993-12-20 NZ NZ259597A patent/NZ259597A/en unknown
- 1993-12-20 WO PCT/SE1993/001090 patent/WO1994015959A1/en not_active Application Discontinuation
- 1993-12-20 SK SK839-95A patent/SK83995A3/sk unknown
- 1993-12-20 EP EP94904365A patent/EP0678099A1/en not_active Withdrawn
- 1993-12-20 AU AU58448/94A patent/AU681372B2/en not_active Ceased
- 1993-12-20 CA CA002152380A patent/CA2152380A1/en not_active Abandoned
- 1993-12-20 JP JP6515914A patent/JPH08505386A/ja active Pending
- 1993-12-20 CZ CZ951711A patent/CZ171195A3/cs unknown
- 1993-12-20 PL PL93309778A patent/PL309778A1/xx unknown
- 1993-12-24 IL IL10816993A patent/IL108169A0/xx unknown
- 1993-12-27 IS IS4115A patent/IS4115A/is unknown
-
1994
- 1994-01-04 US US08/176,938 patent/US5602099A/en not_active Expired - Fee Related
- 1994-01-04 MX MX9400255A patent/MX9400255A/es unknown
- 1994-01-05 AP APAP/P/1994/000605A patent/AP508A/en active
- 1994-01-05 ZA ZA9455A patent/ZA9455B/xx unknown
- 1994-01-05 YU YU394A patent/YU394A/sh unknown
- 1994-01-05 SI SI9400005A patent/SI9400005A/sl unknown
- 1994-01-05 CN CN94100129A patent/CN1096515A/zh active Pending
- 1994-11-03 EE EE9400326A patent/EE9400326A/xx unknown
-
1995
- 1995-06-29 LV LVP-95-197A patent/LV10962B/en unknown
- 1995-07-04 FI FI953302A patent/FI953302A0/fi unknown
- 1995-07-04 NO NO952650A patent/NO952650L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ171195A3 (en) | 1996-09-11 |
NZ259597A (en) | 1996-07-26 |
AP508A (en) | 1996-07-22 |
HU9502041D0 (en) | 1995-09-28 |
YU394A (sh) | 1997-07-31 |
AU5844894A (en) | 1994-08-15 |
IL108169A0 (en) | 1994-04-12 |
PL309778A1 (en) | 1995-11-13 |
JPH08505386A (ja) | 1996-06-11 |
MX9400255A (es) | 1994-07-29 |
LV10962B (en) | 1997-04-20 |
LV10962A (lv) | 1995-12-20 |
WO1994015959A1 (en) | 1994-07-21 |
FI953302A (fi) | 1995-07-04 |
SK83995A3 (en) | 1996-09-04 |
ZA9455B (en) | 1994-07-05 |
KR960700269A (ko) | 1996-01-19 |
FI953302A0 (fi) | 1995-07-04 |
EE9400326A (et) | 1996-04-15 |
NO952650L (no) | 1995-08-30 |
CA2152380A1 (en) | 1994-07-21 |
IS4115A (is) | 1994-07-06 |
NO952650D0 (no) | 1995-07-04 |
EP0678099A1 (en) | 1995-10-25 |
AU681372B2 (en) | 1997-08-28 |
HUT72597A (en) | 1996-05-28 |
CN1096515A (zh) | 1994-12-21 |
AP9400605A0 (en) | 1994-01-31 |
US5602099A (en) | 1997-02-11 |
SE9300012D0 (sv) | 1993-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI9400005A (en) | Novel opioid peptide analogs | |
US5919897A (en) | MU opioid receptor ligands: agonists and antagonists | |
US5455230A (en) | Delta opioid receptor antagonists and their use as analgesic agents | |
US5811400A (en) | Peptide derivatives with δ opioid receptor antagonist or mixed μ agδ antagonist effects | |
US4103005A (en) | Novel-enkephalin analogs | |
HU185229B (en) | Process for preparing pharmaceutically active peptides and acetates thereof | |
EP0853484B1 (en) | Novel mu opioid receptor ligands: agonists and antagonists | |
US5733881A (en) | Opioid peptide antagonists | |
US5786447A (en) | Opioid peptide analogs | |
AU691630C (en) | New opioid peptide antagonists | |
US6150335A (en) | Tic-containing opioid dipeptide derivatives useful as analgesics | |
EP0777682A1 (en) | New opioid peptide antagonists | |
MAEDA et al. | Amino acids and peptides. XXIII. Leu-enkephalin analogs containing a fluorinated amino acid at position 2, 4 or 5 | |
Di Marzoc et al. | Luigi Longobardo,* Dominique Melck, c Rosa Siciliano, b Antonello Santini |